[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE425751T1 - Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel - Google Patents

Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel

Info

Publication number
ATE425751T1
ATE425751T1 AT05712747T AT05712747T ATE425751T1 AT E425751 T1 ATE425751 T1 AT E425751T1 AT 05712747 T AT05712747 T AT 05712747T AT 05712747 T AT05712747 T AT 05712747T AT E425751 T1 ATE425751 T1 AT E425751T1
Authority
AT
Austria
Prior art keywords
closantel
organic amine
amine salt
composition containing
antiparasitic composition
Prior art date
Application number
AT05712747T
Other languages
English (en)
Inventor
Robert Albright
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE425751T1 publication Critical patent/ATE425751T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/44Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT05712747T 2004-02-02 2005-01-28 Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel ATE425751T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54116204P 2004-02-02 2004-02-02

Publications (1)

Publication Number Publication Date
ATE425751T1 true ATE425751T1 (de) 2009-04-15

Family

ID=34837467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05712747T ATE425751T1 (de) 2004-02-02 2005-01-28 Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel

Country Status (11)

Country Link
US (1) US7666444B2 (de)
EP (2) EP1713466B1 (de)
AT (1) ATE425751T1 (de)
AU (1) AU2005210660A1 (de)
BR (1) BRPI0507333A (de)
CA (1) CA2553039A1 (de)
DE (1) DE602005013360D1 (de)
ES (1) ES2323137T3 (de)
MX (1) MXPA06008751A (de)
NZ (1) NZ548689A (de)
WO (1) WO2005074912A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1824474A1 (de) * 2004-12-10 2007-08-29 Bayer HealthCare AG Wurmmittel
US8097266B2 (en) * 2007-11-26 2012-01-17 Merial Limited Solvent systems for pour-on formulations for combating parasites
AU2013201461B2 (en) * 2007-11-26 2015-10-29 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
EP2416663A2 (de) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Parasitizide formulierung
GB201021836D0 (en) * 2010-12-21 2011-02-02 Norbrook Lab Ltd Topical Composition
EP3967312A1 (de) 2014-09-12 2022-03-16 UNION therapeutics A/S Antibakterielle verwendung halogenierter salicylanilide
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN110279657B (zh) * 2019-07-29 2021-07-27 河南官渡生物工程有限公司 一种氯氰碘柳胺钠注射液及其制备方法
SI3815677T1 (sl) 2019-10-30 2023-12-29 Krka, D.D., Novo Mesto Stabilni veterinarski sestavek, ki obsega moksidektin in imidakloprid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005218A (en) * 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
WO1994028887A1 (en) 1993-06-15 1994-12-22 The Australian National University Synergistic anthelmintic compositions
NZ248486A (en) 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AUPQ875700A0 (en) 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
CN1375287A (zh) 2001-03-16 2002-10-23 王玉万 含氯氰碘柳胺或其钠盐的兽用混悬注射剂
AU2003215011A1 (en) 2002-02-08 2003-09-02 Mcneil-Ppc, Inc. Topical ivermectin composition
GB2386067A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
FR2839614B1 (fr) 2002-05-14 2004-08-13 Virbac Sa Nouvelles compositions orales huileuses antiparasitaires
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
AU2002952597A0 (en) 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
WO2004047803A1 (fr) 2002-11-27 2004-06-10 Eco Animal Health Ltd Injection de medicament pour animaux renfermant du closantel ou du sodium de closantel
WO2004089239A2 (en) 2003-04-04 2004-10-21 Merial Ltd. Topical anthelmintic veterinary formulations

Also Published As

Publication number Publication date
ES2323137T3 (es) 2009-07-07
US20050197302A1 (en) 2005-09-08
DE602005013360D1 (de) 2009-04-30
WO2005074912A3 (en) 2006-04-20
EP2065042A3 (de) 2009-07-22
EP2065042A2 (de) 2009-06-03
MXPA06008751A (es) 2007-01-19
NZ548689A (en) 2010-06-25
BRPI0507333A (pt) 2007-07-03
WO2005074912A2 (en) 2005-08-18
AU2005210660A1 (en) 2005-08-18
CA2553039A1 (en) 2005-08-18
US7666444B2 (en) 2010-02-23
EP1713466A2 (de) 2006-10-25
EP1713466B1 (de) 2009-03-18

Similar Documents

Publication Publication Date Title
AR057914A1 (es) Compuestos organicos de azufre y su uso
ATE425751T1 (de) Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel
EA201070881A1 (ru) Полихромные вещества и их применение
EA200800873A1 (ru) Конденсированные гетероциклические соединения, полезные в качестве модуляторов киназы
EA200701121A1 (ru) Потенциаторы рецепторов глутамата
ATE513842T1 (de) Neue dihydropseudoerythromycinderivate
CR8831A (es) Compuestos y metodos para el tratamiento de dislipidemia
ECSP077130A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos
DE602005007488D1 (de) Zusammensetzung mit interkalierten funktionell aktiven organischen verbindungen
NO20064175L (no) Heterosyklisk forbindelse
HK1164114A1 (en) Antidepressant containing heterocyclic compound having specific structure
DE602004005888D1 (de) Herstellung von selbstorganisierten monoschichten
GB0521508D0 (en) Organic compounds
ATE502075T1 (de) Kautschukzusammensetzungen
ATE550013T1 (de) Zink-konservierungszusammensetzung und anwendungsverfahren
EA200701476A1 (ru) Новые гетероциклические соединения оксима, способ их получения и фармацевтические композиции, которые их содержат
ATE529413T1 (de) Verfahren zur synthese von aryloxydiaminopyrimidinen
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
IN2014DN04588A (de)
ATE382609T1 (de) Malononitrilverbindungen als pestizide
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
AR043714A1 (es) Aductos en base a compuestos ciclicos y su utilizacion como agentes para curtir y conservantes
TW200611606A (en) Organic electroluminescent material and organic electroluminescent device by using the same
GT200200250A (es) Compuestos hexaciclicos
DE602004010530D1 (de) Verfahren zur herstellung von phenyltetrazolderivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties